pimecrolimus NDC 0591-2944

NDC codes

FDA NDC Directory

Product NDC (as listed)0591-2944Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00591-2944Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0591-2944-30	00591294430	30 g in 1 TUBE (0591-2944-30)Marketed from Dec 27, 2018
0591-2944-60	00591294460	60 g in 1 TUBE (0591-2944-60)Marketed from Dec 27, 2018
0591-2944-87	00591294487	100 g in 1 TUBE (0591-2944-87)Marketed from Dec 27, 2018

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): pimecrolimus
Generic name (nonproprietary): pimecrolimus
Active ingredients: Pimecrolimus — 10 mg/g
Dosage form: Cream
Route: Topical
Labeler: Actavis Pharma, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209345
Marketing start: Dec 27, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Calcineurin Inhibitors (Mechanism)
Identifiers: Product ID 0591-2944_a3f0bc92-796c-4f74-8c7a-63001b4e9e43SPL ID a3f0bc92-796c-4f74-8c7a-63001b4e9e43SPL set ID d5b0403a-065f-42e3-96d6-7dcb9ab127d3RxCUI 562806UNII 7KYV510875
Pharmacologic class: Calcineurin Inhibitor Immunosuppressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400591294430 followed by a unit qualifier and the quantity

Package 00591-2944-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 7, 2018. This label includes a boxed warning.

Indications (excerpt from the label)

Pimecrolimus cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatments, or when those treatments are not advisable. Pimecrolimus c ream, 1% is not indicated for use in children less than 2 years of age [see Warnings and Precautions (5.1) , Use in Specific Populations (8.4) ]. Pimecrolimus cream, 1% is a calcineurin inhibitor immunosuppressant indicated as s e c o n d -l i n e th e r a p y for the short-term and non-continuous chronic treatment of mild to moderate …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)